TC
Turkes, Cuneyt
22 yayın · 948 atıf · 2021–2026
Yayın
22
Atıf
948
Yıllar
6
Yayınlar
| Başlık | Yıl | Tip | Atıf |
|---|---|---|---|
|
1,4-Naphthoquinone thiazole urea hybrids bearing morpholine/piperazine: synthesis, crystal structure, aldose reductase and α-glycosidase enzyme inhibition, molecular docking, and electrochemical interaction with dsDNA
|
2026 | Article | 13 |
|
Esculetin attenuates doxorubicin-induced cardiac toxicity: Evidence from gene expression, enzyme activity, and molecular docking analyses
|
2026 | Article | 22 |
|
Design, synthesis,<i> in</i><i> vitro</i> and<i> in</i><i> silico</i> evaluation of thiazole-hydrazine hybrids incorporating an isoindole-1,3-dione scaffold as potent α-glucosidase inhibitors
|
2026 | Article | 0 |
|
Synthesis, characterization, and lipoxygenase inhibition of salicylaldehyde-derived schiff base metal complexes: enzymatic and in silico evaluation using quinoa lipoxygenase
|
2026 | Article | 0 |
|
Rhodanine-Sulfonate hybrids targeting aldose reductase: Synthesis, in vitro inhibition, molecular docking, and cytotoxicity studies
|
2025 | Article | 2 |
|
Esculetin Attenuates Doxorubicin-Induced Cardiotoxicity via Modulation of Apoptotic and Mitochondrial Gene Expression Networks
|
2025 | Article | 13 |
|
New 1,2,3-triazole derivatives as acetylcholinesterase and carbonic anhydrase inhibitors: Synthesis, molecular docking, and solubility
|
2025 | Article | 8 |
|
A new series of naphthyl-thiosemicarbazone and thio/carbohydrazone derivatives: Synthesis, spectroscopic elucidation, dual enzyme inhibition targeting carbonic anhydrase/acetylcholinesterase and molecular docking studies
|
2025 | Article | 4 |
|
Bioactivity, cytotoxicity, and molecular modeling studies of novel sulfonamides as dual inhibitors of carbonic anhydrases and acetylcholinesterase
|
2024 | Article | 65 |
|
Dynamics of small molecule-enzyme interactions: Novel benzenesulfonamides as multi-target agents endowed with inhibitory effects against some metabolic enzymes
|
2024 | Article | 26 |
|
Novel spiroindoline derivatives targeting aldose reductase against diabetic complications: Bioactivity, cytotoxicity, and molecular modeling studies
|
2024 | Article | 73 |
|
Molecular Docking Studies and the Effect of Fluorophenylthiourea Derivatives on Glutathione-Dependent Enzymes
|
2023 | Article | 24 |
|
Synthesis and characterization of novel acyl hydrazones derived from vanillin as potential aldose reductase inhibitors
|
2023 | Article | 88 |
|
Synthesis, biological evaluation, and in silico study of novel library sulfonates containing quinazolin-4(3<i>H</i>)-one derivatives as potential aldose reductase inhibitors
|
2022 | Article | 90 |
|
Molecular docking and inhibition studies of vulpinic, carnosic and usnic acids on polyol pathway enzymes
|
2022 | Article | 98 |
|
Novel inhibitors with sulfamethazine backbone: synthesis and biological study of multi-target cholinesterases and α-glucosidase inhibitors
|
2022 | Article | 91 |
|
Biological evaluation and in silico study of benzohydrazide derivatives as paraoxonase 1 inhibitors
|
2022 | Article | 27 |
|
Methyl benzoate derivatives: in vitro Paraoxonase 1 inhibition and in silico studies
|
2022 | Article | 21 |
|
Cytotoxic effect, enzyme inhibition, and in silico studies of some novel <i>N</i>-substituted sulfonyl amides incorporating 1,3,4-oxadiazol structural motif
|
2022 | Article | 77 |
|
Calcium Channel Blockers: The Effect of Glutathione S-Transferase Enzyme Activity and Molecular Docking Studies
|
2021 | Article | 21 |
|
Synthesis, Characterization, and Inhibition Study of Novel Substituted Phenylureido Sulfaguanidine Derivatives as α-Glycosidase and Cholinesterase Inhibitors
|
2021 | Article | 80 |
|
Benzenesulfonamide derivatives as potent acetylcholinesterase, α-glycosidase, and glutathione S-transferase inhibitors: biological evaluation and molecular docking studies
|
2021 | Article | 105 |